stars 1 stars 2 stars 3

Combining our aptamer design expertise with novel assays and devices, AuramerBio provides customisable sensing solutions for medical and environmental research, and beyond. We work with a range of clients to develop aptamers suitable for their needs. Our team's expertise with small molecule targets is illustrated by our growing catalogue of gold standard hormone binding aptamers. We are currently developing biosensors for application in the drugs of abuse, female fertility, nutrition, and environmental contaminant markets. The company was founded in 2015 and is based in Wellington, New Zealand.

AuramerBio Questions

The AuramerBio annual revenue was $6 million in 2026.

Geoff Todd is the Director of AuramerBio.

1 people are employed at AuramerBio.

The NAICS codes for AuramerBio are [5417, 541713, 541, 54, 54171].

The SIC codes for AuramerBio are [873, 87].

Top AuramerBio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users